TROT, I hear what you're saying and can truthfully understand your thoughts.
I would like to counter this with, it is preferable to me to have XERI in it's present state and thinly traded. It could be a company (pardon the mention of other companies on this board) like OPTI or INKW that trade in the 10's of millions of shares on a daily basis and are essentially nothing but a churn pit of people moving in and out for fractions of a cent with scores of people losing their rear ends on a daily basis to people whose only existence is to monitor insider level trading info and feed like piranhas.
The companies that are traded in that manner with LOTS of volume have no appeal to an INVESTOR. I view XERI as an investment. Yeah, it's down from its highs in February. But, like SP2 always tells us, it is WAY UP from the dismal days.
A company can't tell us they've sold something that they haven't. They can portray a picture of things to come. If all of this is a ruse, then they're going WAY out of their way to do it. Pump and dumps can be done for much cheaper than this, the OTC is littered with their corpses.
XERI is an infant but it is, I believe, about ready to walk and then run...maybe even FLY!
Is their PROOF? In sales? Not yet provided. Therefore I understand from where you're asking the questions and doubting. But down here in OTC land you either find something you believe in and are patient or you churn with the types of companies that are mentioned above.
I wish you the best man, I really do.
Market Data 
Markets 
AI
